the latest figures are out , and according to drugs com , the no best selling drug in america in dollar volume is now abilify , an atypical antipsychotic the no drug in the u s in terms of number of prescriptions is oxycodone abilify otherwise known as aripiprazole was approved by the u s food and drug administration for schizophrenia on november , it got approval by the european medicines agency on june it goes off patent in october until then , there is no generic formulation source drugs com why is an atypical antipsychotic drug suddenly selling so well in the u s ? several reasons abilify is widely prescribed as an adjunctive or supplemental medication for depression korea otsuka pharmaceutical co , ltd , which markets abilify jointly with bristol myers squibb bms , received fda approval for the drug 's use as an adjunct for major depressive disorder on november , and to treat irritability in children with autism on november but that 's not the whole story abilify is also widely prescribed off label , to treat a variety of conditions in children , plus dementia alzheimer 's disease in the elderly while it 's not illegal for doctors to prescribe drugs in an off label way , the off label use of antipsychotic drugs for children , especially is ill advised , given the potential for adverse side effects and the lack of efficacy data for such uses it should be noted that bristol myers squibb was fined million in september for recommending off label uses of abilify among other charges one thing is certain abilify did n't make it to the top of the charts by virtue of its efficacy which , as an adjunct to antidepressants , is only slightly better than placebo it made it there , in part , by a massive advertising campaign in the u s that urged americans to their doctor and ask if abilify is right for you it also made it to the best seller list by a variety of flat out underhanded marketing practices bristol myers squibb 's settlement agreement with the u s government was based on the justice department 's contention that bms knowingly and willfully paid illegal remuneration to physicians and other health care providers to induce them to purchase bms drugs bms paid the illegal remuneration in the form of consulting fees and expenses to physicians and other health care providers to participate in various consulting programs , advisory boards , and preceptorships some of these programs involved travel to luxurious resorts the government also alleged that , from through , apothecon a bms wholly owned subsidiary knowingly and willfully paid illegal remuneration such as stocking allowances , price protection payments , prebates , market share payments , and free goods in order to induce its retail pharmacy and wholesaler customers to purchase its products from press release it 's a simple formula for success , really come up with a drug that works no better than older medications , for a condition schizophrenia that only in people have announce that it 's a wonder drug pay doctors to prescribe it encourage physicians to find untested uses for it pay stocking allowances to drug stores tell consumers who almost certainly do n't need it to ask their doctor for it and meanwhile set its price so high that it 's to times more valuable , ounce for ounce , than pure gold what could possibly go wrong ?